Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Nakopoulou

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Journal of Cellular and Molecular Medicine|November 28, 2006
Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injuryTheodoros I Kassimatis, Ioanna Giannopoulou, Dimitra Koumoundourou, et al.
Renal Failure|July 17, 2014
Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluationKonstantinos Koutroutsos, Theodoros I Kassimatis, Alexandros Nomikos, et al.
Renal Failure|August 21, 2010
Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexedAristeidis Stavroulopoulos, Lydia Nakopoulou, Antonios M Xydakis, et al.
Anticancer Research|April 20, 2006
MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomasAndreas C Lazaris, Aristeidis Zarogiannos, Nikolaos Kavantzas, et al.
Gynecologic Oncology|December 8, 2006
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinomaEleni Mylona, Paraskevi Alexandrou, Ioanna Giannopoulou, et al.
Human Pathology|May 23, 2008
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomasEleni Mylona, Ioanna Giannopoulou, Emmanouil Fasomytakis, et al.
Anticancer Research|August 6, 2005
Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancerJohn Mavrommatis, Eleni Mylona, Hariklia Gakiopoulou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2006
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcomeLydia Nakopoulou, Eleni Mylona, Ioanna Papadaki, et al.
Histopathology|April 5, 2013
An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)-3β in invasive breast carcinomasEleni Mylona, Ioannis Vamvakaris, Ioanna Giannopoulou, et al.
Pathology, Research and Practice|June 21, 2014
Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomasEleni Mylona, Savvas Melissaris, Alexandros Nomikos, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Journal of Cellular and Molecular Medicine|November 28, 2006
Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injuryTheodoros I Kassimatis, Ioanna Giannopoulou, Dimitra Koumoundourou, et al.
Renal Failure|July 17, 2014
Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluationKonstantinos Koutroutsos, Theodoros I Kassimatis, Alexandros Nomikos, et al.
Renal Failure|August 21, 2010
Interstitial nephritis and nephrogenic diabetes insipidus in a patient treated with pemetrexedAristeidis Stavroulopoulos, Lydia Nakopoulou, Antonios M Xydakis, et al.
Anticancer Research|April 20, 2006
MLH1 mismatch repair gene product is associated with apoptotic potential of urothelial bladder carcinomasAndreas C Lazaris, Aristeidis Zarogiannos, Nikolaos Kavantzas, et al.
Gynecologic Oncology|December 8, 2006
The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinomaEleni Mylona, Paraskevi Alexandrou, Ioanna Giannopoulou, et al.
Human Pathology|May 23, 2008
The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomasEleni Mylona, Ioanna Giannopoulou, Emmanouil Fasomytakis, et al.
Anticancer Research|August 6, 2005
Nuclear hTERT immunohistochemical expression is associated with survival of patients with urothelial bladder cancerJohn Mavrommatis, Eleni Mylona, Hariklia Gakiopoulou, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2006
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcomeLydia Nakopoulou, Eleni Mylona, Ioanna Papadaki, et al.
Histopathology|April 5, 2013
An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)-3β in invasive breast carcinomasEleni Mylona, Ioannis Vamvakaris, Ioanna Giannopoulou, et al.
Pathology, Research and Practice|June 21, 2014
Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomasEleni Mylona, Savvas Melissaris, Alexandros Nomikos, et al.
Pageof 6